Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
89 mg/mL
(200.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 22 mg/mL |
| Water | Insoluble |
| DMSO |
89 mg/mL
(200.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 89 mg/mL |
| Water | Insoluble |
| DMSO |
89 mg/mL
(200.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 89 mg/mL |
| Water | Insoluble |
| DMSO |
89 mg/mL
(200.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 45 mg/mL |
| Water | Insoluble |
| DMSO |
89 mg/mL
(200.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 22 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Check the
MLN4924 (Pevonedistat)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
|
Concentration
Volume
Mass
|
|---|
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
Batch:
| Administration Route | Formulation Type | Formulation Details | Solubility | Preparation Method |
|---|
Other Animals:
- MLN4924 (Pevonedistat) Mechanism of Action: NAE Inhibition in Hematopoietic Cancer Cell Research
- MLN4924 (Pevonedistat) Clinical Trials
- MLN4924 (Pevonedistat): Selectivity & Specificity
- MLN4924 (Pevonedistat) Working Concentration | Cell Culture | Treatment
- MLN4924 (Pevonedistat) Stock Solution
- MLN4924 (Pevonedistat) Storage
- MLN4924 (Pevonedistat) Stability
- MLN4924 (Pevonedistat) Combination Database
- MLN4924 (Pevonedistat) Molecular Weight
- MLN4924 (Pevonedistat) SMILES
- MLN4924 (Pevonedistat) CAS Number
- MLN4924 (Pevonedistat) Chemical Structure (2D and 3D)
- MLN4924 (Pevonedistat) IC50 for Cell-based and Cell-free Assays
- MLN4924 (Pevonedistat) Sigma (5.05477)? Try a better option.
- MLN4924 (Pevonedistat) MedChemExpress (HY-70062)? Try a better option.
- MLN4924 (Pevonedistat) Cell Signaling Technology (85923)? Try a better option.
- MLN4924 (Pevonedistat) STEMCELL (74184)? Try a better option.
- MLN4924 (Pevonedistat) Cayman (15217)? Try a better option.
- MLN4924 (Pevonedistat) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.